Date

Tuesday, 05 January 2010

Location

European Medicines Agency, Amsterdam, the Netherlands

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases. It does not currently publish the minutes or agendas of its meetings. It does publish a meeting report after each meeting.

Documents

Committee for Orphan Medicinal Products (COMP) - Monthly report from the January 2010 meeting

How useful do you find this page?